N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide

C128H178F2N12O13 — CID 159674548

IUPACN-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide
SMILESCCCCOc1c(C)cc(C(=O)NC2CCN(Cc3ccccc3)CC2)cc1C.CCCCOc1c(C)cc(C(=O)NCC2(N(C)C)CCC(F)(F)CC2)cc1C.Cc1cc(C(=O)NCC2(N3CCN(C)CC3)CCCCC2)cc(C)c1OCc1ccccc1.Cc1cc(C(=O)NCC2(N3CCN(C)CC3)CCOCC2)cc(C)c1OCc1ccccc1.Cc1cc(C(=O)NCC2(N3CCOCC3)CCOCC2)cc(C)c1OCc1ccccc1
InChIInChI=1S/C28H39N3O2.C27H37N3O3.C26H34N2O4.C25H34N2O2.C22H34F2N2O2/c1-22-18-25(19-23(2)26(22)33-20-24-10-6-4-7-11-24)27(32)29-21-28(12-8-5-9-13-28)31-16-14-30(3)15-17-31;1-21-17-24(18-22(2)25(21)33-19-23-7-5-4-6-8-23)26(31)28-20-27(9-15-32-16-10-27)30-13-11-29(3)12-14-30;1-20-16-23(17-21(2)24(20)32-18-22-6-4-3-5-7-22)25(29)27-19-26(8-12-30-13-9-26)28-10-14-31-15-11-28;1-4-5-15-29-24-19(2)16-22(17-20(24)3)25(28)26-23-11-13-27(14-12-23)18-21-9-7-6-8-10-21;1-6-7-12-28-19-16(2)13-18(14-17(19)3)20(27)25-15-21(26(4)5)8-10-22(23,24)11-9-21/h4,6-7,10-11,18-19H,5,8-9,12-17,20-21H2,1-3H3,(H,29,32);4-8,17-18H,9-16,19-20H2,1-3H3,(H,28,31);3-7,16-17H,8-15,18-19H2,1-2H3,(H,27,29);6-10,16-17,23H,4-5,11-15,18H2,1-3H3,(H,26,28);13-14H,6-12,15H2,1-5H3,(H,25,27)
InChIKeyMUKUJSAVLDRAPO-UHFFFAOYSA-N
MW2130.90 g/mol
LogP21.06
Rot. Bonds37

About N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide

N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide (PubChem CID 159674548) has the molecular formula C128H178F2N12O13 and a molecular weight of 2130.90 g/mol. Its IUPAC name is N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide.

Molecular Properties

Compound NameN-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide
PubChem CID159674548
Molecular FormulaC128H178F2N12O13
Molecular Weight2130.90 g/mol
Exact Mass2129.36
IUPAC NameN-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide
SMILESCCCCOc1c(C)cc(C(=O)NC2CCN(Cc3ccccc3)CC2)cc1C.CCCCOc1c(C)cc(C(=O)NCC2(N(C)C)CCC(F)(F)CC2)cc1C.Cc1cc(C(=O)NCC2(N3CCN(C)CC3)CCCCC2)cc(C)c1OCc1ccccc1.Cc1cc(C(=O)NCC2(N3CCN(C)CC3)CCOCC2)cc(C)c1OCc1ccccc1.Cc1cc(C(=O)NCC2(N3CCOCC3)CCOCC2)cc(C)c1OCc1ccccc1
InChIInChI=1S/C28H39N3O2.C27H37N3O3.C26H34N2O4.C25H34N2O2.C22H34F2N2O2/c1-22-18-25(19-23(2)26(22)33-20-24-10-6-4-7-11-24)27(32)29-21-28(12-8-5-9-13-28)31-16-14-30(3)15-17-31;1-21-17-24(18-22(2)25(21)33-19-23-7-5-4-6-8-23)26(31)28-20-27(9-15-32-16-10-27)30-13-11-29(3)12-14-30;1-20-16-23(17-21(2)24(20)32-18-22-6-4-3-5-7-22)25(29)27-19-26(8-12-30-13-9-26)28-10-14-31-15-11-28;1-4-5-15-29-24-19(2)16-22(17-20(24)3)25(28)26-23-11-13-27(14-12-23)18-21-9-7-6-8-10-21;1-6-7-12-28-19-16(2)13-18(14-17(19)3)20(27)25-15-21(26(4)5)8-10-22(23,24)11-9-21/h4,6-7,10-11,18-19H,5,8-9,12-17,20-21H2,1-3H3,(H,29,32);4-8,17-18H,9-16,19-20H2,1-3H3,(H,28,31);3-7,16-17H,8-15,18-19H2,1-2H3,(H,27,29);6-10,16-17,23H,4-5,11-15,18H2,1-3H3,(H,26,28);13-14H,6-12,15H2,1-5H3,(H,25,27)
InChIKeyMUKUJSAVLDRAPO-UHFFFAOYSA-N
XLogP21.06
TPSA242.02 Ų
H-Bond Donors5
H-Bond Acceptors20
Rotatable Bonds37
Heavy Atoms155
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002130.90
LogP ≤ 521.06
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide?
The IUPAC name of N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide (CID 159674548) is N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide.
What is the SMILES notation for N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide?
The canonical SMILES for N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide is CCCCOc1c(C)cc(C(=O)NC2CCN(Cc3ccccc3)CC2)cc1C.CCCCOc1c(C)cc(C(=O)NCC2(N(C)C)CCC(F)(F)CC2)cc1C.Cc1cc(C(=O)NCC2(N3CCN(C)CC3)CCCCC2)cc(C)c1OCc1ccccc1.Cc1cc(C(=O)NCC2(N3CCN(C)CC3)CCOCC2)cc(C)c1OCc1ccccc1.Cc1cc(C(=O)NCC2(N3CCOCC3)CCOCC2)cc(C)c1OCc1ccccc1.
What is the InChIKey of N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide?
The InChIKey is MUKUJSAVLDRAPO-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H39N3O2.C27H37N3O3.C26H34N2O4.C25H34N2O2.C22H34F2N2O2/c1-22-18-25(19-23(2)26(22)33-20-24-10-6-4-7-11-24)27(32)29-21-28(12-8-5-9-13-28)31-16-14-30(3)15-17-31;1-21-17-24(18-22(2)25(21)33-19-23-7-5-4-6-8-23)26(31)28-20-27(9-15-32-16-10-27)30-13-11-29(3)12-14-30;1-20-16-23(17-21(2)24(20)32-18-22-6-4-3-5-7-22)25(29)27-19-26(8-12-30-13-9-26)28-10-14-31-15-11-28;1-4-5-15-29-24-19(2)16-22(17-20(24)3)25(28)26-23-11-13-27(14-12-23)18-21-9-7-6-8-10-21;1-6-7-12-28-19-16(2)13-18(14-17(19)3)20(27)25-15-21(26(4)5)8-10-22(23,24)11-9-21/h4,6-7,10-11,18-19H,5,8-9,12-17,20-21H2,1-3H3,(H,29,32);4-8,17-18H,9-16,19-20H2,1-3H3,(H,28,31);3-7,16-17H,8-15,18-19H2,1-2H3,(H,27,29);6-10,16-17,23H,4-5,11-15,18H2,1-3H3,(H,26,28);13-14H,6-12,15H2,1-5H3,(H,25,27).
What are the key properties of N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide?
N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide has a molecular weight of 2130.90 g/mol, XLogP of 21.06, 37 rotatable bonds, 5 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-benzylpiperidin-4-yl)-4-butoxy-3,5-dimethylbenzamide;4-butoxy-N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethylbenzamide;3,5-dimethyl-N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[[4-(4-methylpiperazin-1-yl)oxan-4-yl]methyl]-4-phenylmethoxybenzamide;3,5-dimethyl-N-[(4-morpholin-4-yloxan-4-yl)methyl]-4-phenylmethoxybenzamide is sourced from PubChem (CID 159674548), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).